Abstract
Today, advances in cross-sectional imaging have led to the detection and early recognition of incidental/focal liver lesions (FCL). In approximately 17,000 cases of chest CT, incidental liver lesions were found in 6% [1]. In general, FCL consists of hepatocytes, biliary epithelium, mesenchymal tissue, connective tissue, or metastasized cells from distant sites. Most incidental lesions are benign, some may require careful management and treatment. In evaluating the lesion, the patient's clinical history, underlying disease and age factor should be considered. FCL can be detected at a rate of 10-30% in normal healthy and chronic liver disease patients, and even in oncology patients with malignancy, FCLs can be highly benign (50-80%)
Highlights
Most incidental lesions are benign, some may require careful management and treatment
Diagnosis and treatment should be decided whether it is necessary or not. Factors affecting this decision are the presence of other diseases, laboratory and radiological data
When a lesion is detected in the liver; - Does it pose a risk for the patient in the future? - Is it possible to differentiate between benign and malignant? - Does the lesion cause complications? parameters such as If the lesion is
Summary
Vedat Goral 1*, Kerem Mert Goral 2, Necati Ormeci 3 1 Istanbul Medipol University School of Medicine Department of Gastroenterology. Received date: December 03, 2021; Accepted date: December 24, 2021; Published date: January 11, 2022
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
